
Moxifloxacin (0.5% w/v)
Active composition
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medical applications
Moxidrop Eye Drop is a sterile, preservative-free solution containing 0.5% w/v of moxifloxacin, a fluoroquinolone antibacterial agent. It is indicated for the treatment of bacterial conjunctivitis, including purulent conjunctivitis, and for the reduction of inflammation and suppression of bacterial conjunctivitis. Moxidrop Eye Drop is administered topically, 2-3 times a day, as needed, and is available in 5mL or 10mL dropper bottles. The solution is clear, colorless, and free of particles. The pH is within the physiological range of 6.0-7.5. Moxidrop Eye Drop is contraindicated in patients with a known hypersensitivity to moxifloxacin, and should be used with caution in patients with a history of ocular surface disease or increased intraocular pressure. Common adverse reactions include burning sensation, stinging, and itching, which typically resolve without treatment. Rarely, patients may experience blurred vision, increased lacrimation, and conjunctival redness. As with any medication, the potential for systemic absorption and the risk of adverse reactions must be considered. Moxidrop Eye Drop should be used under the guidance of a healthcare professional and in accordance with the product label and package insert.
Fluoroquinolone
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Moxidrop Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Moxidrop Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Moxidrop Eye Drop may cause side effects which could affect your ability to drive. Moxidrop Eye Drop may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Moxidrop Eye Drop

Moxifloxacin (0.5% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medical applications
Moxidrop Eye Drop is a sterile, preservative-free solution containing 0.5% w/v of moxifloxacin, a fluoroquinolone antibacterial agent. It is indicated for the treatment of bacterial conjunctivitis, including purulent conjunctivitis, and for the reduction of inflammation and suppression of bacterial conjunctivitis. Moxidrop Eye Drop is administered topically, 2-3 times a day, as needed, and is available in 5mL or 10mL dropper bottles. The solution is clear, colorless, and free of particles. The pH is within the physiological range of 6.0-7.5. Moxidrop Eye Drop is contraindicated in patients with a known hypersensitivity to moxifloxacin, and should be used with caution in patients with a history of ocular surface disease or increased intraocular pressure. Common adverse reactions include burning sensation, stinging, and itching, which typically resolve without treatment. Rarely, patients may experience blurred vision, increased lacrimation, and conjunctival redness. As with any medication, the potential for systemic absorption and the risk of adverse reactions must be considered. Moxidrop Eye Drop should be used under the guidance of a healthcare professional and in accordance with the product label and package insert.
Fluoroquinolone
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Moxidrop Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Moxidrop Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Moxidrop Eye Drop may cause side effects which could affect your ability to drive. Moxidrop Eye Drop may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Moxidrop Eye Drop















